The Board has overall responsibility for promoting Mereo’s success for the benefit of all stakeholders – from our partners and investors to our patients and employees. Our Board includes members who have held executive leadership positions within the biopharmaceutical and biotechnology industries. Our Board brings with them diverse and complimentary skill sets.
Dr. Denise Scots-Knight
Chief Executive Officer
Dr. Jeremy Bender
Non-Executive Director
Dr. Anders Ekblom
Non-Executive Director
Dr. Pierre Jacquet
Non-Executive Director
Dr. Annalisa Jenkins
Non-Executive Director
Dr. Deepa Pakianathan
Non-Executive Director
Justin Roberts
Non-Executive Director
Dr. Daniel Shames
Non-Executive Director
Marc Yoskowitz
Non-Executive Director